Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01829984 · ClinicalTrials.gov registry record
Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 51
- Enrollment target
NCT01829984: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01829984 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01829984 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two different ways of teaching people how to give injections at home. The first is what we do now, which is teaching patients and/or their caregivers verbally and by giving written instructions. The second is what we do now (verbal and written instructions) along with a demonstration and practice using a needle and an injection pad that feels similar to skin and fat. This is being done to find the best method for teaching people to give an injection at home.
Primary Outcome
with verbal and written teaching + simulation using an injection model, in terms of: * Patient/caregiver satisfaction * Patient/caregiver self-confidence * Nurse satisfaction
Interventions
- OTHER Verbal and Written Instruction
- OTHER Verbal and Written Plus Simulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-09 |
What the finished NCT01829984 record still lists
NCT01829984 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Verbal and Written Instruction is the first listed.
NCT01829984 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01829984 about?
NCT01829984 is a clinical study titled "Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers". The purpose of this study is to compare two different ways of teaching people how to give injections at home. The first is what we do now, which is teaching patients and/or their caregivers verbally and by giving written instructions. The second is what we do now (verbal and written instructions) al...
What is the current status of trial NCT01829984?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2013-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01829984?
The interventions under investigation include: Verbal and Written Instruction (OTHER), Verbal and Written Plus Simulation (OTHER).
Who is sponsoring clinical trial NCT01829984?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia